OneSource Specialty Pharma has informed that it enclosed Press Release titled ‘OneSource announces strong financial results in its first quarter postlisting; Q3FY25 revenues at ?3,926 million with an EBITDA of ?1,432 million, demonstrating a 36.5% EBITDA margin’ (along with Earnings presentation) issued by the Company. The Board Meeting commenced at 06:30 hrs IST and concluded at 07:15 hrs IST. The above information is also available on the website of the Company: https://www.onesourcecdmo.com/investor-relations/stock-exchange-intimation/.
The above information is a part of company’s filings submitted to BSE.
